A detailed history of State Of Wyoming transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, State Of Wyoming holds 1,503 shares of NBIX stock, worth $185,304. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,503
Previous 1,376 9.23%
Holding current value
$185,304
Previous $189,000 8.47%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$114.58 - $153.15 $14,551 - $19,450
127 Added 9.23%
1,503 $173,000
Q2 2024

Aug 14, 2024

BUY
$130.86 - $143.19 $180,063 - $197,029
1,376 New
1,376 $189,000
Q4 2023

Feb 14, 2024

BUY
$106.07 - $132.76 $17,501 - $21,905
165 Added 28.25%
749 $98,000
Q3 2023

Nov 14, 2023

BUY
$94.02 - $117.1 $54,907 - $68,386
584 New
584 $65,000
Q1 2023

May 12, 2023

BUY
$94.11 - $123.02 $10,352 - $13,532
110 Added 6.26%
1,866 $188,000
Q4 2022

Feb 14, 2023

BUY
$106.72 - $127.06 $155,491 - $185,126
1,457 Added 487.29%
1,756 $209,000
Q3 2022

Nov 14, 2022

BUY
$92.03 - $107.81 $22,179 - $25,982
241 Added 415.52%
299 $32,000
Q2 2022

Aug 15, 2022

BUY
$75.79 - $100.07 $1,061 - $1,400
14 Added 31.82%
58 $6,000
Q1 2022

May 13, 2022

BUY
$72.45 - $94.81 $579 - $758
8 Added 22.22%
44 $4,000
Q4 2021

Feb 11, 2022

SELL
$79.65 - $106.22 $238 - $318
-3 Reduced 7.69%
36 $3,000
Q3 2021

Feb 11, 2022

SELL
$86.18 - $99.03 $1,551 - $1,782
-18 Reduced 31.58%
39 $4,000
Q2 2021

Feb 11, 2022

BUY
$89.43 - $102.27 $2,682 - $3,068
30 Added 111.11%
57 $6,000
Q1 2021

Feb 08, 2022

BUY
$87.57 - $119.4 $2,364 - $3,223
27 New
27 $3,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.